C12N 2760/16145
Special targeting system for viral vectors
C12N2760/16145 (Special targeting system for viral vectors) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 5
- Assignees
- 2
- Inventors
- 6
- Latest grant
- 19 Nov 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
By publication year.
Recent patents
- Influenza virus vector for virotherapy19 Nov 2019US 10,480,013 B2Blue Sky Vaccines GmbH
- Influenza virus vector for virotherapy13 Nov 2018US 10,125,374 B2Blue Sky Vaccines GmbH
- Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy25 May 2010US 7,723,094 B2Wisconsin Alumni Research Foundation
- System and Method for the Universal Destruction of Cancer Cells without Toxicity5 Aug 2021US 2021/0238633 A1
- Method for Precise Identification, Targeting and Delivery of Directed Therapies for Destruction of Cancerous Cells23 Jan 2020US 2020/0024615 A1
- Novel influenza virus vector for virotherapy31 Jan 2019US 2019/0032084 A1Blue Sky Vaccines GmbH
- Novel influenza virus vector for virotherapy15 Sep 2016US 2016/0264996 A1Blue Sky Vaccines GmbH
- Recombinant influenza vectors with a PolII promoter and ribozymes for vaccines and gene therapy17 Feb 2005US 2005/0037487 A1Wisconsin Alumni Research Foundation
Most cited
By later US patents